def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
|
|
Filed by the Registrant |
|
þ |
|
|
|
|
|
|
|
|
|
Filed by a Party other than the Registrant |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Check the appropriate box: |
|
|
|
|
|
|
|
|
|
|
|
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
|
|
|
|
|
|
|
o |
|
Preliminary Proxy Statement |
|
|
|
|
|
|
|
|
|
þ |
|
Definitive Proxy Statement |
|
|
|
|
|
|
|
|
|
o |
|
Definitive Additional Materials |
|
|
|
|
|
|
|
|
|
o |
|
Soliciting Material Pursuant to § 240.14a-11(c) or § 240.14a-12 |
NANOPHASE TECHNOLOGIES CORPORATION
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of filing fee (Check the appropriate box):
þ No fee required
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
o Fee paid previously with preliminary materials.
o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
2) Form, Schedule or Registration Statement No.:
3) Filing Party:
4) Date Filed:
1319 Marquette Drive
Romeoville, Illinois 60446
June 23, 2006
Dear Stockholder:
On behalf of the Board of Directors, I invite you to attend the
2006 Annual Meeting of Stockholders of Nanophase Technologies
Corporation to be held at Nanophase Technologies Corporation,
1319 Marquette Drive, Romeoville, Illinois, on Monday,
July 24, 2006 at 9:30 a.m., local time. The formal
notice of the Annual Meeting appears on the following page.
The attached Notice of Annual Meeting and Proxy Statement
describe the matters that we expect to be acted upon at the
Annual Meeting. Management will be available to answer any
questions you may have immediately after the Annual Meeting.
Whether or not you choose to attend the Annual Meeting, it is
important that your shares be represented. Regardless of the
number of shares you own, please sign and date the enclosed
proxy card and promptly return it to us in the enclosed postage
paid envelope. If you sign and return your proxy card without
specifying your choices, your shares will be voted in accordance
with the recommendations of the Board of Directors contained in
the Proxy Statement.
You are welcome to attend the July 24, 2006 meeting, and I
urge you to return your proxy card as soon as possible.
|
|
|
Sincerely, |
|
|
|
|
|
Joseph E. Cross |
|
President and Chief Executive Officer |
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JULY 24, 2006
To the Stockholders of
Nanophase Technologies Corporation:
The Annual Meeting of Stockholders of Nanophase Technologies
Corporation (the Company) will be held at
9:30 a.m., Chicago time, on Monday, July 24, 2006, at
Nanophase Technologies Corporation, 1319 Marquette Drive,
Romeoville, Illinois, for the following purposes:
|
|
|
(1) To elect two Class III directors to the
Companys Board of Directors; |
|
|
(2) To authorize an amendment to the Companys
Certificate of Incorporation to increase the authorized number
of shares of common stock from 25,000,000 to 30,000,000; |
|
|
(3) To authorize an amendment to the 2004 Equity
Compensation Plan (the Plan) to (a) increase to
1,200,000 the aggregate number of shares available to be issued
under the Plan, (b) increase the annual limit on the number
of shares available to be issued under the Plan to 300,000
(subject to existing exceptions contained in the Plan), and
(c) decrease the cap on grants to any individual in any
year to 10% of any class; and |
|
|
(4) To transact such other business as may properly come
before the meeting or any adjournments thereof. |
The foregoing items of business are more fully described in the
accompanying Proxy Statement.
The Board of Directors has fixed the close of business on
May 30, 2006 as the record date for determining
stockholders entitled to notice of, and to vote at, the Annual
Meeting.
|
|
|
By order of the Board of Directors, |
|
|
|
|
|
Jess Jankowski |
|
Secretary |
Romeoville, Illinois
June 23, 2006
ALL STOCKHOLDERS ARE URGED TO ATTEND THE MEETING IN PERSON OR
BY PROXY. WHETHER OR NOT YOU EXPECT TO BE PRESENT AT THE
MEETING, PLEASE COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD
AND RETURN IT PROMPTLY IN THE ENCLOSED POSTAGE PAID ENVELOPE
FURNISHED FOR THAT PURPOSE.
TABLE OF CONTENTS
NANOPHASE TECHNOLOGIES CORPORATION
1319 Marquette Drive
Romeoville, Illinois 60446
(630) 771-6708
PROXY STATEMENT
The accompanying proxy is solicited by the Board of Directors
(the Board of Directors) of Nanophase Technologies
Corporation, a Delaware corporation (the Company),
for use at the Annual Meeting of Stockholders (the Annual
Meeting) to be held at 9:30 a.m., Chicago time,
Monday, July 24, 2006, at Nanophase Technologies
Corporation, 1319 Marquette Drive, Romeoville, Illinois, and any
adjournments thereof. This Proxy Statement and accompanying form
of proxy are first being mailed to stockholders on or about
June 23, 2006.
Record Date and Outstanding Shares The Board
of Directors has fixed the close of business on May 30,
2006, as the record date (the Record Date) for the
determination of stockholders entitled to notice of, and to vote
at, the Annual Meeting or any adjournments thereof. As of the
Record Date, the Company had outstanding 18,004,464 shares
of Common Stock, par value $.01 per share (the Common
Stock). Each outstanding share of Common Stock is entitled
to one vote on all matters to come before the Annual Meeting.
Voting of Proxies Joseph E. Cross and Jess
Jankowski, the persons named as proxies on the proxy card
accompanying this Proxy Statement, were selected by the Board of
Directors to serve in such capacity. Messrs. Cross and
Jankowski are executive officers of the Company and
Mr. Cross is also a director of the Company. The shares
represented by each executed and returned proxy will be voted in
accordance with the directions indicated thereon, or, if no
direction is indicated, such proxy will be voted in accordance
with the recommendations of the Board of Directors contained in
this Proxy Statement. Each stockholder giving a proxy has the
power to revoke it at any time before the shares it represents
are voted. Revocation of a proxy is effective upon receipt by
the Secretary of the Company of either (1) an instrument
revoking the proxy or (2) a duly executed proxy bearing a
later date. Additionally, a stockholder may change or revoke a
previously executed proxy by voting in person at the Annual
Meeting (attendance at the Annual Meeting will not, by itself,
revoke a proxy).
Required Vote The vote of a plurality of the
shares of Common Stock voted in person or by proxy is required
to elect the nominees for Class III director. The
affirmative vote of a majority of the outstanding shares of
Common Stock is required to approve the amendment to the
Companys Certificate of Incorporation increasing the
Companys authorized Common Stock. The affirmative vote of
a majority of the shares of Common Stock represented in person
or by proxy is required to approve the amendment to the
Companys 2004 Equity Compensation Plan. Stockholders will
not be allowed to cumulate their votes in the election of
directors.
Quorum; Abstentions and Broker Non-Votes The
required quorum for transaction of business at the Annual
Meeting will be a majority of the shares of Common Stock issued
and outstanding as of the Record Date. Votes cast by proxy or in
person at the Annual Meeting will be tabulated by the election
inspectors appointed for the meeting and will determine whether
or not a quorum is present. Abstentions and broker non-votes
will be included in determining the presence of a quorum.
Abstentions and broker non-votes will have no effect on the vote
for directors. With respect to approving the amendment to the
Companys Certificate of Incorporation, abstentions and
broker non-votes will be considered present and entitled to vote
and will have the same effect as votes Against such
proposal. With respect to approving the amendment to the
Companys 2004 Equity Compensation Plan, abstentions will
be considered present and entitled to vote and will have the
same effect as votes Against such proposal, while
broker non-votes will not be considered present and entitled to
vote and will have no effect on such proposal.
Annual Report to Stockholders The
Companys Annual Report to Stockholders for the year ended
December 31, 2005, containing financial and other
information pertaining to the Company, is being furnished to
stockholders simultaneously with this Proxy Statement.
PROPOSAL 1
ELECTION OF DIRECTORS
The Companys Board of Directors currently consists of
seven directors. Article VI of the Companys
Certificate of Incorporation provides that the Board of
Directors shall be classified with respect to the terms for
which its members shall hold office by dividing the members into
three classes. At the Annual Meeting, two directors of
Class III will be elected for a term of three years
expiring at the Companys 2009 Annual Meeting of
Stockholders. The nominees are presently serving as directors of
the Company. See Nominees below.
The five directors whose terms of office do not expire in 2006
will continue to serve after the Annual Meeting until such time
as their respective terms of office expire or their successors
are duly elected and qualified. See Other Directors
below.
If at the time of the Annual Meeting the nominees should be
unable or decline to serve, the persons named in the proxy will
vote for such substitute nominee as the Board of Directors
recommends, or vote to allow the vacancy created thereby to
remain open until filled by the Board of Directors, as the Board
of Directors recommends. The Board of Directors has no reason to
believe that the nominees will be unable or decline to serve as
a director if elected.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE STOCKHOLDERS VOTE
FOR THE ELECTION OF THE NOMINEES NAMED BELOW.
NOMINEES
The names of the nominees for the office of director, together
with certain information concerning such nominees, is set forth
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Served as | |
|
|
|
|
Name |
|
Director Since | |
|
Age | |
|
Position with Company |
|
|
| |
|
| |
|
|
Donald S. Perkins
|
|
|
1998 |
|
|
|
79 |
|
|
Chairman of the Board of Directors |
Jerry K. Pearlman
|
|
|
1999 |
|
|
|
67 |
|
|
Director |
Mr. Perkins has served as a director of the Company
since February 1998. Mr. Perkins retired from Jewel
Companies, Inc., the retail supermarket and drug chain, in 1983.
He had been with Jewel since 1953, serving as President from
1965 to 1970, as Chairman of the Board of Directors from 1970 to
1980, and as Chairman of the Executive Committee until his
retirement. He has served on a number of corporate boards and is
currently a director of LaSalle Hotel Properties and
La Salle U.S. Realty Income and Growth Funds II
and III. For more than 30 years, he has served on
corporate boards including AT&T, Aon, Corning, Cummins
Engine, Eastman Kodak, Firestone, Inland Steel Industries,
Kmart, Lucent Technologies, The Putnam Funds, Springs Industries
and Time-Warner, Inc. He is Protector of the Thyssen-Bornemisza
Continuity Trust. He has served as a Trustee of The Ford
Foundation and The Brookings Institution and as a member of The
Business Council. Mr. Perkins is a life trustee and was
Vice Chairman of the Board of Trustees of Northwestern
University. He co-chaired Campaign/Northwestern, a
university-wide effort which has raised more than
$1.5 billion. He is also a member of the Civic Committee of
The Commercial Club of Chicago, RoundTable Healthcare Partners
L.P. Advisory Boards, Northwestern Universitys School of
Communication and School of Education and Social Policy Advisory
Boards. Mr. Perkins holds a B.A. degree from Yale
University and an M.B.A. degree from the Harvard Graduate School
of Business Administration.
Mr. Pearlman has served as a director of the Company
since April 1999. Mr. Pearlman retired as Chairman of
Zenith Electronics Corporation in November 1995. He joined
Zenith as controller in 1971 and
2
served as chief executive officer from 1983 through April 1995.
Mr. Pearlman is a director of Smurfit Stone Container
Corporation and Ryerson Inc. He is a trustee of Northwestern
University and a life director and past chairman of the board of
Evanston Northwestern Healthcare. Mr. Pearlman graduated
from Princeton with honors from the Woodrow Wilson School and
from Harvard Business School with highest honors.
THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE FOR
THE NOMINEES FOR ELECTION AS CLASS III DIRECTORS.
OTHER DIRECTORS
The following persons will continue to serve as directors of the
Company after the Annual Meeting until their terms of office
expire (as indicated below) or until their successors are duly
elected and qualified.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Served as | |
|
Term | |
|
|
Name |
|
Age | |
|
Position with Company |
|
Director Since | |
|
Expires | |
|
Class | |
|
|
| |
|
|
|
| |
|
| |
|
| |
James A. McClung
|
|
|
68 |
|
|
Director |
|
|
2000 |
|
|
|
2007 |
|
|
|
I |
|
James A. Henderson
|
|
|
71 |
|
|
Director |
|
|
2001 |
|
|
|
2007 |
|
|
|
I |
|
R. Janet Whitmore
|
|
|
51 |
|
|
Director |
|
|
2003 |
|
|
|
2007 |
|
|
|
I |
|
Richard W. Siegel, Ph D.
|
|
|
69 |
|
|
Director |
|
|
1989 |
|
|
|
2008 |
|
|
|
II |
|
Joseph E. Cross
|
|
|
58 |
|
|
Director, President and Chief Executive Officer |
|
|
1998 |
|
|
|
2008 |
|
|
|
II |
|
Mr. McClung has served as a director of the Company
since February 2000. He retired as Senior Vice President and
executive officer for FMC Corporation, a leading producer of a
diversified portfolio of chemicals and machinery. He has over
30 years of international business development experience
in over 75 countries, having managed and developed new
technologies and production processes for diversified global
businesses, including specialized chemicals and machinery, while
living in the United States, Europe and Africa. Mr. McClung
currently serves as Corporate Board member of Alticor (Amway),
Beaulieu of America Corporation, NCCI Holdings and Hu-Friedy. He
was a founding member of the
U.S.-Russia Business
Council and is active in other international business
organizations, such as the Japan American Society, Chicago
Council of Foreign Relations and the Economic Club of Chicago.
He serves as a board director at Thunderbird: The Garvin School
of International Management and the College of Wooster (Ohio).
Mr. McClung earned a Bachelors degree from the
College of Wooster, a Masters degree from the University
of Kansas and a Doctorate from Michigan State University.
Mr. Henderson has served as a director of the
Company since July 2001. He retired as Chairman and Chief
Executive Officer of Cummins Engine Company in December 1999,
after joining the company in 1964. Mr. Henderson became
President and Chief Operating Officer of Cummins in 1977, was
promoted to President and Chief Executive Officer in 1994 and
served as Chairman and Chief Executive Officer from 1995 until
his retirement in 1999. Mr. Henderson attended Culver
Military Academy, holds an A.B. in public and international
affairs from Princeton University and an M.B.A. from Harvard
Business School. Mr. Henderson currently serves as a member
of the Board of Directors of ATT Inc., International Paper and
Ryerson Inc. He serves as Chairman of the Board of the Culver
Education Foundation and is a past Chair of the Executive
Committee of the Princeton University Board of trustees.
Ms. Whitmore joined the board in November 2003. She
is currently a director of Silverleaf Resorts, Inc., where she
serves as Chairman of the Compensation Committee and as a member
of the Audit Committee. She is a former director of Epoch
Biosciences, a supplier of proprietary products used to
accelerate genomic analysis. Ms. Whitmore is Founder of
Benton Consulting, LLC, which specializes in business
development and processes. From 1976 through 1999,
Ms. Whitmore held numerous engineering and finance
positions at Mobil Corporation, including Mobils Chief
Financial Analyst and Controller of Mobils Global
Petrochemicals Division. Ms. Whitmore holds a Bachelor of
Science degree in Chemical Engineering from Purdue University
and an M.B.A. from Lewis University.
3
Dr. Siegel is a co-founder of the Company and has
served as a director of the Company since 1989. Dr. Siegel
served as a consultant to the Company from 1990 to 2002 with
regard to the application and commercialization of
nanocrystalline materials. Dr. Siegel is an internationally
recognized scientist in the field of nanocrystalline materials.
During his tenure on the research staff at Argonne National
Laboratory from July 1974 to May 1995, he was the principal
scientist engaged in research with the laboratory-scale
synthesis process that was the progenitor of the Companys
physical-vapor-synthesis production system. Dr. Siegel has
been the Robert W. Hunt Professor in Materials Science and
Engineering at Rensselaer Polytechnic Institute since June 1995,
and served as Department Head from 1995 to 2000. In April 2001,
Dr. Siegel became the founding Director of the newly
created Rensselaer Nanotechnology Center at the Institute.
During 1995-1998, he was also a visiting professor at the Max
Planck Institute for Microstructure Physics in Germany on an
Alexander von Humboldt Research Prize received in 1994. During
2003-2004 he was a visiting professor in Japan on a RIKEN
Eminent Scientist Award. He chaired the World Technology
Evaluation Center worldwide study of nanostructure science and
technology for the U.S. government, has served on the
Council of the Materials Research Society and as Chairman of the
International Committee on Nanostructured Materials. He also
served on the Committee on Materials with
Sub-Micron Sized
Microstructures of the National Materials Advisory Board and was
the co-chairman of the Study Panel on Clusters and
Cluster-Assembled Materials for the U.S. Department of
Energy. He currently serves on the Nanotechnology Technical
Advisory Group to the U.S. Presidents Council of
Advisors on Science and Technology. Dr. Siegel holds an
A.B. degree in physics from Williams College and an M.S. degree
and Ph.D. from the University of Illinois at Urbana-Champaign.
Mr. Cross has served as Chief Executive Officer of
the Company since December 1998 and President and a director of
the Company since joining the Company in November 1998. Prior to
joining the Company in November 1998, Mr. Cross served as
President and Chief Executive Officer of Aptech, a manufacturer
of measurement, metering and control devices for the utility
industry, from August 1996 to October 1998. From December 1993
to July 1996, Mr. Cross served as President of Aegis
Technologies, an interactive telecommunications company. He
holds a B.S. degree from Southwest Missouri University and
attended the M.B.A. program at Southwest Missouri University.
Director Compensation Upon first being
elected to the Board of Directors, each director of the Company
who is not an employee or consultant of the Company (an
Outside Director) is granted stock options to
purchase 10,000 shares of common stock at the fair
market value of the common stock, as determined by a committee
appointed by the Board of Directors, as of the date of issuance
of such stock options. This initial option grant to an Outside
Director vests over five years. Prior to 2004, on or after the
date of each annual meeting of the stockholders of the Company,
each Outside Director who was re-elected or continued to serve
as an Outside Director because his or her term had not expired
was granted stock options to purchase 2,000 shares of
common stock provided that such grant was not made to an Outside
Director who was first elected to the Board of Directors within
three months prior to such annual meeting. The options granted
annually to Outside Directors vest in three equal annual
installments beginning on the first anniversary of the date of
grant. All options granted to Outside Directors expire ten years
from the date of grant.
Prior to 2004, the Company also paid Outside Directors a
combination of restricted common stock and cash so that the
total value of the compensation equaled approximately
$25,000 per year. In 2005 and 2004, the Company paid $6,250
quarterly, which amounted to an annual total of $25,000 per
Outside Director, in cash compensation for services performed in
their capacity as directors. No stock based awards were issued
to Outside Directors in 2005 and 2004. Beginning in 2004,
Mr. McClungs cash compensation is being paid to
Lismore International, Incorporated.
On January 17, 2003, the Company granted 4,870 restricted
shares of common stock to each of Donald Perkins, Richard
Siegel, Jerry Pearlman, James McClung and James Henderson. The
Company also agreed to issue a cash payment of $10,000 as part
of 2003 compensation to its outside directors. All Outside
Directors are reimbursed for their reasonable
out-of-pocket expenses
incurred in attending board and committee meetings.
4
In 2005, the Company adopted, and the Shareholders
approved, the Nanophase Technologies Corporation 2005
Non-Employee Director Restricted Stock Plan (the Director
Restricted Stock Plan) which reserves 150,000 shares
of the Companys common stock to be issued to Outside
Directors in the form of restricted shares. In 2005, no awards
were made under the Director Restricted Stock Plan. In 2005, the
Company also adopted the Nanophase Technologies Corporation
Non-Employee Director Deferred Compensation Plan (the
Director Deferred Compensation Plan) which permits
an Outside Director to defer the receipt of director fees until
separation from service or the Company undergoes a change in
control. The Company amended the Director Restricted Stock Plan
in 2005 to permit an Outside Director to defer receipt of
restricted stock granted under it. The deferred restricted
shares are accounted for under the Director Deferred
Compensation Plan and issued upon separation from service or the
Companys change in control. Under the Director Deferred
Compensation Plan, the deferred fees that would have been paid
in cash are deemed invested in 5 year U.S. Treasury
Bonds during the deferral period. The accumulated hypothetical
earnings are paid following the Outside Directors
separation from service or the Companys change in control.
The deferred fees that would have been paid as restricted shares
are deemed invested in common stock of the Company during the
deferral period. The Director Deferred Compensation Plan is an
unfunded, nonqualified deferred compensation arrangement. In
2005, no amounts were deferred under the Director Deferred
Compensation Plan.
Meetings of the Board and Committees During
the year ended December 31, 2005, the Board of Directors
held thirteen formal meetings. No director missed more than one
board and committee meeting held during 2005 (for all committees
on which a particular director served).
Committees of the Board of Directors The
Board of Directors has established an Audit and Finance
Committee, Compensation and Governance Committee and a
Nominating Committee each comprised entirely of independent
directors who are not officers or employees of the Company. The
members of the Audit and Finance Committee are Mr. McClung
(Chairman), Mr. Pearlman and Mr. Perkins. The members
of the Compensation and Governance Committee are
Mr. Pearlman (Chairman), Mr. Henderson and
Mr. Perkins. The members of the Nominating Committee are
Mr. Henderson (Chairman), Mr. McClung,
Mr. Pearlman, Mr. Perkins and Dr. Siegel.
The Audit and Finance Committee generally has responsibility for
retaining the Companys independent public auditors,
reviewing the plan and scope of the accountants annual
audit, reviewing the Companys internal control functions
and financial management policies and reporting to the Board of
Directors regarding all of the foregoing. The Audit and Finance
Committee held seven formal meetings in 2005. The Board of
Directors has determined that Mr. Pearlman and
Mr. Perkins, both of whom serve on the Audit and Finance
Committee, are audit committee financial experts as
described in applicable SEC rules. Each member of the Audit and
Finance Committee is independent, as defined in
Rule 4200(a) (15) of the National Association of
Securities Dealers listing standards and applicable SEC
rules.
The Compensation and Governance Committee generally has
responsibility for recommending to the Board of Directors
guidelines and standards relating to the determination of
executive and key employee compensation, reviewing the
Companys executive compensation and general corporate
governance policies and reporting to the Board of Directors
regarding the foregoing. The Compensation and Governance
Committee also has responsibility for administering the 2004
Equity Compensation Plan, determining the number of options, if
any, to be granted to the Companys employees and
consultants pursuant to the 2004 Equity Compensation Plan and
reporting to the Board of Directors regarding the foregoing. The
Compensation and Governance Committee held five formal meetings
in 2005.
The Nominating Committee generally has responsibility for
nominating candidates to serve on the Board of Directors. All
members of the Nominating Committee are independent. The
Nominating Committee was formed in 2004 and held one formal
meeting in 2005.
Communications with the Board of Directors
Any stockholder desiring to communicate with the Board of
Directors or one or more of its directors may send a letter
addressed to the Board of Directors or the applicable directors
in care of the Corporate Secretary at Nanophase Technologies
Corporation, 1319 Marquette Drive, Romeoville, Illinois
60446. All such communications must have the senders name,
address,
5
telephone number and
e-mail address, if any,
as well as a statement of the type and amount of the
Companys securities the sender holds and any other
interest of the sender in the subject of the communication or,
if the sender is not a stockholder of the Company, a statement
of the nature of the senders interest in the Company.
Communications will be forwarded to the proper recipient unless
they (a) concern individual grievances or other interests
that could not reasonably be construed to be of concern to the
stockholders or other constituencies of the Company,
(b) advocate the Companys engaging in illegal
activities, (c) contain offensive, scurrilous or abusive
content, or (d) have no rational relevance to the business
or operations of the Company.
Directors Attendance at Annual Meetings
When a director is unable to attend an Annual Meeting of
Stockholders in person, but is able to attend by electronic
conferencing, the Company will arrange for the director to
participate by means such that the director can hear and be
heard by those present at the meeting. The entire Board of
Directors attended the Companys 2005 Annual Meeting of
Stockholders.
EXECUTIVE OFFICERS
The table below identifies executive officers of the Company who
are not identified in the tables entitled Election of
Directors Nominees or Other
Directors.
|
|
|
|
|
|
|
Name |
|
Age | |
|
Position |
|
|
| |
|
|
Jess Jankowski
|
|
|
40 |
|
|
Chief Financial Officer, Vice President of Finance, Secretary
and Treasurer |
Robert Haines
|
|
|
55 |
|
|
Vice President Operations |
Daniel S. Bilicki
|
|
|
62 |
|
|
Vice President Sales and Marketing |
Richard W. Brotzman, Ph.D.
|
|
|
53 |
|
|
Vice President Research and Development |
Mr. Jankowski has served as Controller of the
Company since joining in 1995. He was elected Secretary and
Treasurer in November 1999, Acting Chief Financial Officer in
January 2000 and Vice President in April of 2002 and Vice
President of Finance and Chief Financial Officer in April of
2004. From 1990-1995 he served as Controller for two building
contractors in the Chicago area. From 1986 to 1990 he worked for
Kemper Financial Services in their accounting control corporate
compliance unit, serving as unit supervisor during his last two
years. Mr. Jankowski holds a B.S. in accountancy from
Northern Illinois University, an M.B.A. from Loyola University,
and received his certified public accountant certificate from
the State of Illinois. He has served on the advisory board of
WESTEC, an Illinois Technology Enterprise Center focusing on the
commercialization of advanced manufacturing technologies, since
2003. Mr. Jankowski was appointed to the Romeoville
Economic Development Commission in 2004.
Mr. Haines joined Nanophase Technologies in January
2001 as Vice President of Operations. Beginning in 1996 and
prior to joining Nanophase, he served as Corporate Director of
Quality at Legrand North America. Previous experience
includes two years as Vice President of Operations for Aegis
Technologies and eight years with Digital Equipment Corporation.
Mr. Haines has a B.S. in Chemistry/ Engineering Physics
from East Tennessee State University.
Mr. Bilicki has served as Vice President
Sales and Marketing of the Company since joining the Company in
March 1999. From January 1996 until March 1999, Mr. Bilicki
served as President/ Director of PT Crosfield Indonesia in
Jakarta, Indonesia, a subsidiary of Crosfield Company, which is
a global chemical company. From January 1994 to December 1995,
Mr. Bilicki held the position of President/ Director
North America of Crosfield Company. He holds a B.S. degree
from Indiana Institute of Technology and an M.B.A. degree from
Winthrop University.
Dr. Brotzman joined the Company in July 1994 as a
senior scientist and has served as Vice President
Research and Development of the Company since July 1996. He is
the inventor of much of the Companys coating technology.
Dr. Brotzman has 15 years experience in research and
development of advanced materials leading to new products. His
technical areas of expertise include interfacial adhesion and
chemistry, self-assembled polymeric coatings, nanosized
inorganic powders, powder processing, reactive coupling agents,
6
solgel derived protective coatings, non-destructive evaluation
of composites, neo-debye relaxation in green inorganic gels,
asymmetric membranes and plasma processing. From January 1991 to
July 1994, Dr. Brotzman served as Director of Research at
TPL, Inc., an advanced materials company. He holds a B.S. degree
in chemical engineering from Lafayette College, an M.S. degree
in engineering and applied science from the University of
California, Davis and a Ph.D. in chemistry from the University
of Washington.
The Board of Directors elects executive officers annually, and
such executive officers, subject to the terms of certain
employment agreements, serve at the discretion of the Board of
Directors. Messrs. Cross, Jankowski, Bilicki, Haines and
Dr. Brotzman each have employment agreements with the
Company. See Executive Compensation
Employment. There are no family relationships among any of
the directors or officers of the Company.
EXECUTIVE COMPENSATION
The following table provides information concerning the annual
and long-term compensation for services in all capacities to the
Company for the years ended December 31, 2005, 2004 and
2003 of those persons who were (1) during 2005, the chief
executive officer of the Company and (2) on
December 31, 2005, the four other most highly compensated
(based upon combined salary and bonus) executive officers of the
Company whose total salary and bonus exceeded $100,000 during
2005 (collectively, the Named Officers).
|
|
I. |
Summary Compensation Table |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term | |
|
|
|
|
|
|
|
|
|
|
Compensation Awards | |
|
Payouts | |
|
|
|
|
|
|
Annual Compensation | |
|
| |
|
| |
|
|
|
|
|
|
| |
|
Restricted | |
|
Securities | |
|
|
|
|
Name and |
|
|
|
|
|
Other Annual | |
|
Stock | |
|
Underlying | |
|
LTIP | |
|
All Other | |
Principal Position |
|
Year | |
|
Salary ($) | |
|
Bonus ($)(1) | |
|
Compensation ($) | |
|
Awards(s) ($) | |
|
Options | |
|
Payouts ($) | |
|
Compensation ($) | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Joseph E. Cross
|
|
|
2005 |
|
|
$ |
320,000 |
|
|
$ |
30,000 |
|
|
$ |
0 |
|
|
$ |
15,075 |
|
|
|
15,000 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
President and Chief |
|
|
2004 |
|
|
|
320,000 |
|
|
|
15,000 |
|
|
|
0 |
|
|
|
13,875 |
|
|
|
20,000 |
|
|
|
0 |
|
|
|
0 |
|
|
Executive Officer |
|
|
2003 |
|
|
|
305,000 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
50,000 |
|
|
|
0 |
|
|
|
0 |
|
Daniel S. Bilicki
|
|
|
2005 |
|
|
$ |
212,000 |
|
|
$ |
8,000 |
|
|
$ |
0 |
|
|
$ |
9,045 |
|
|
|
9,000 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
Vice President Sales |
|
|
2004 |
|
|
|
212,000 |
|
|
|
10,000 |
|
|
|
0 |
|
|
|
8,325 |
|
|
|
12,300 |
|
|
|
0 |
|
|
|
0 |
|
|
and Marketing |
|
|
2003 |
|
|
|
205,000 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
21,000 |
|
|
|
0 |
|
|
|
0 |
|
Robert Haines
|
|
|
2005 |
|
|
$ |
202,000 |
|
|
$ |
20,000 |
|
|
$ |
0 |
|
|
$ |
9,045 |
|
|
|
10,000 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
Vice President |
|
|
2004 |
|
|
|
202,000 |
|
|
|
15,000 |
|
|
|
0 |
|
|
|
8,325 |
|
|
|
14,000 |
|
|
|
0 |
|
|
|
0 |
|
|
Operations |
|
|
2003 |
|
|
|
192,500 |
|
|
|
20,000 |
|
|
|
0 |
|
|
|
0 |
|
|
|
30,000 |
|
|
|
0 |
|
|
|
0 |
|
Richard Brotzman, Ph.D.
|
|
|
2005 |
|
|
$ |
184,000 |
|
|
$ |
15,000 |
|
|
$ |
0 |
|
|
$ |
9,045 |
|
|
|
10,000 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
Vice President Research |
|
|
2004 |
|
|
|
184,000 |
|
|
|
10,000 |
|
|
|
0 |
|
|
|
8,325 |
|
|
|
14,000 |
|
|
|
0 |
|
|
|
0 |
|
|
and Development |
|
|
2003 |
|
|
|
175,000 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
20,000 |
|
|
|
0 |
|
|
|
0 |
|
Jess Jankowski
|
|
|
2005 |
|
|
$ |
167,500 |
|
|
$ |
10,000 |
|
|
$ |
0 |
|
|
$ |
9,045 |
|
|
|
10,000 |
|
|
$ |
0 |
|
|
$ |
0 |
|
|
Chief Financial Officer, |
|
|
2004 |
|
|
|
167,500 |
|
|
|
10,000 |
|
|
|
0 |
|
|
|
8,325 |
|
|
|
14,000 |
|
|
|
0 |
|
|
|
0 |
|
|
Vice President of |
|
|
2003 |
|
|
|
137,500 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
18,000 |
|
|
|
0 |
|
|
|
0 |
|
|
Finance, Secretary and Treasurer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
See the Long-Term Incentive Awards Table below for additional
performance compensation granted in 2005. |
7
OPTION GRANTS IN 2005 The following table
provides information on grants of stock options to the Named
Officers during 2005. No stock appreciation rights were granted
to the Named Officers during 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual Grants | |
|
|
|
Potential Realizable | |
|
|
|
|
| |
|
|
|
Value at Assumed | |
|
|
Number of | |
|
Percent of | |
|
|
|
|
|
Annual Rates of Stock | |
|
|
Securities | |
|
Total Options | |
|
|
|
|
|
Price Appreciation for | |
|
|
Underlying | |
|
Granted to | |
|
Exercise or | |
|
|
|
Option Term(2) | |
|
|
Options | |
|
Employees in | |
|
Base Price | |
|
Expiration | |
|
| |
Name |
|
Granted (#)(1) | |
|
Fiscal Year | |
|
($/SH) | |
|
Date | |
|
50% ($) | |
|
10% ($) | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Joseph E. Cross
|
|
|
15,000 |
|
|
|
15.00 |
% |
|
$ |
6.03 |
|
|
|
09/27/15 |
|
|
$ |
5,125,353 |
|
|
$ |
144,154 |
|
Robert Haines
|
|
|
10,000 |
|
|
|
10.00 |
% |
|
|
6.03 |
|
|
|
09/27/15 |
|
|
|
3,416,902 |
|
|
|
96,103 |
|
Daniel S. Bilicki
|
|
|
9,000 |
|
|
|
9.00 |
% |
|
|
6.03 |
|
|
|
09/27/15 |
|
|
|
3,075,212 |
|
|
|
86,492 |
|
Richard Brotzman, Ph.D.
|
|
|
10,000 |
|
|
|
10.00 |
% |
|
|
6.03 |
|
|
|
09/27/15 |
|
|
|
3,416,902 |
|
|
|
96,103 |
|
Jess Jankowski
|
|
|
10,000 |
|
|
|
10.00 |
% |
|
|
6.03 |
|
|
|
09/27/15 |
|
|
|
3,416,902 |
|
|
|
96,103 |
|
|
|
(1) |
Options were granted under the 2004 Equity Compensation Plan and
have a grant price that is equal to the fair market value on the
date of grant. These options are all non-qualified stock
options. Subject to certain restrictions, these options become
exercisable in three equal annual installments, beginning on the
first anniversary of the date of grant. These options were
granted on September 27, 2005. |
|
(2) |
Potential realizable value is presented net of the option
exercise price but before any federal or state income taxes
associated with exercise. These amounts represent certain
assumed rates of appreciation only, as mandated by the SEC.
Actual gains will be dependent on the future performance of the
common stock and the option holders continued employment
through the vesting period. The amounts reflected in the table
may not necessarily be realized. |
AGGREGATED OPTION EXERCISES IN 2005 AND YEAR-END 2005 OPTION
VALUES The following table provides information
regarding each of the Named Officers option exercises in
2005 and unexercised options on December 31, 2005.
Aggregated Option Exercises in 2005 and
Year-End 2005 Option Values
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities | |
|
|
|
|
|
|
|
|
Underlying Unexercised | |
|
Value of Unexercised | |
|
|
|
|
|
|
Options at | |
|
In-the-Money Options at | |
|
|
|
|
|
|
Year-End 2005 (#) | |
|
Year-End 2005 ($)(1) | |
|
|
Shares Acquired | |
|
Value | |
|
| |
|
| |
Name |
|
on Exercise (#) | |
|
Realized ($) | |
|
Exercisable | |
|
Unexercisable | |
|
Exercisable | |
|
Unexercisable | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Joseph E. Cross
|
|
|
0 |
|
|
$ |
0 |
|
|
|
443,334 |
|
|
|
41,666 |
|
|
$ |
511,210 |
|
|
$ |
34,165 |
|
Robert Haines
|
|
|
0 |
|
|
|
0 |
|
|
|
87,667 |
|
|
|
33,333 |
|
|
|
40,167 |
|
|
|
20,633 |
|
Daniel S. Bilicki
|
|
|
0 |
|
|
|
0 |
|
|
|
167,100 |
|
|
|
22,200 |
|
|
|
60,920 |
|
|
|
14,550 |
|
Richard Brotzman, Ph.D.
|
|
|
50,000 |
|
|
|
163,868 |
|
|
|
176,681 |
|
|
|
23,999 |
|
|
|
198,071 |
|
|
|
13,999 |
|
Jess Jankowski
|
|
|
0 |
|
|
|
0 |
|
|
|
100,622 |
|
|
|
23,333 |
|
|
|
66,457 |
|
|
|
12,673 |
|
|
|
(1) |
The value per option is calculated by subtracting the exercise
price per option from the closing price of the Common Stock on
the NASDAQ National Market on December 31, 2005, which was
$5.65. |
8
LONG-TERM INCENTIVE AWARDS IN 2005 The
following table provides information regarding each of the Named
Officers performance share awards issued under the
Companys 2004 Equity Compensation Plan:
Long-Term Incentive Awards in 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Future Payouts Under | |
|
|
|
|
|
|
Non-Stock Price-Based Plans | |
|
|
Number of Shares, | |
|
Performance or | |
|
| |
|
|
Units or Other | |
|
Other Period Until | |
|
Threshold | |
|
Target | |
|
Maximum | |
Name |
|
Rights (#) | |
|
Maturity or Payout | |
|
($ or #) | |
|
($ or #) | |
|
($ or #) | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Joseph E. Cross
|
|
|
2,500 |
|
|
|
January 30, 2009 |
|
|
|
2,500 |
|
|
|
2,500 |
|
|
|
2,500 |
|
Robert Haines
|
|
|
1,500 |
|
|
|
January 30, 2009 |
|
|
|
1,500 |
|
|
|
1,500 |
|
|
|
1,500 |
|
Daniel S. Bilicki
|
|
|
1,500 |
|
|
|
January 30, 2009 |
|
|
|
1,500 |
|
|
|
1,500 |
|
|
|
1,500 |
|
Richard Brotzman, Ph.D.
|
|
|
1,500 |
|
|
|
January 30, 2009 |
|
|
|
1,500 |
|
|
|
1,500 |
|
|
|
1,500 |
|
Jess Jankowski
|
|
|
1,500 |
|
|
|
January 30, 2009 |
|
|
|
1,500 |
|
|
|
1,500 |
|
|
|
1,500 |
|
On September 27, 2005, the Company issued each of the Named
Officers performance share awards under the Companys
2004 Equity Compensation Plan. All of the performance shares
vest and become nonforfeitable on January 30, 2009 only if
an established performance goal is attained and the Named
Officer remains employed through January 30, 2009. The
performance goal requires that during any consecutive twelve
month period between October 1, 2005 and
January 30, 2009, the Company must achieve at least
two reporting quarters of positive earnings before interest
(both interest income and interest expense), taxes, depreciation
and amortization. The two reporting quarters do not need to be
consecutive, but must occur within a consecutive twelve month
period contained within the performance period.
Employment
The Company entered into an employment agreement with Joseph E.
Cross dated November 9, 1999 which provides for an annual
base salary of not less than $220,000. In addition,
Mr. Cross received a lump sum payment of $50,000 on the
first anniversary of the commencement of this agreement. The
Company also granted to Mr. Cross options to purchase up to
100,000 shares of Common Stock at an exercise price of
$2.9375 per share and options to purchase up to
50,000 shares of Common Stock at an exercise price of
$2.1875, with options for one-fifth of such shares becoming
exercisable on each of the first five anniversaries of the dates
of grant. No term has been assigned to Mr. Cross
employment agreement. If Mr. Cross is terminated other than
for cause (as such term is defined in
Mr. Cross employment agreement), Mr. Cross will
receive severance benefits in an amount equal to
Mr. Cross base salary for 52 weeks.
Effective as of November 2, 2000, the Company also entered
into an employment agreement with Robert Haines providing for an
annual base salary of not less than $160,000. The Company also
granted to Mr. Haines options to purchase up to
30,000 shares of Common Stock at an exercise price of
$10.1875. No term has been assigned to Mr. Haines
employment agreement. If Mr. Haines is terminated other
than for cause (as such term is defined in
Mr. Hainess employment agreement), Mr. Haines
will receive severance benefits in an amount equal to
Mr. Hainess base salary for 52 weeks.
Effective as of February 17, 2000, the Company also entered
into an employment agreement with Daniel Bilicki providing for
an annual base salary of not less than $165,000. In addition,
Mr. Bilicki was granted options to purchase up to
50,000 shares of Common Stock at an exercise price of
$2.375. No term has been assigned to Mr. Bilickis
employment agreement. If Mr. Bilicki is terminated other than
for cause (as such term is defined in Mr.
Bilickis employment agreement), Mr. Bilicki will
receive severance benefits in an amount equal to
Mr. Bilickis base salary for 52 weeks.
Effective as of September 26, 2001, the Company also
entered into an employment agreement with Dr. Richard
Brotzman providing for an annual base salary of not less than
$146,250. No term has been assigned to Dr. Brotzmans
employment agreement. If Dr. Brotzman is terminated other
than for cause (as such term is defined in
Dr. Brotzmans employment agreement),
Dr. Brotzman will receive severance benefits in an amount
equal to Dr. Brotzmans base salary for 26 weeks.
9
Effective as of February 17, 2000 the Company also entered
into an employment agreement with Mr. Jess Jankowski
providing for an annual base salary of not less than $95,000. No
term has been assigned to Mr. Jankowskis employment
agreement. If Mr. Jankowski is terminated other than for
cause (as such term is defined in
Mr. Jankowskis employment agreement), Mr. Jankowski
will receive severance benefits in an amount equal to
Mr. Jankowskis base salary for 26 weeks.
REPORT OF THE COMPENSATION AND GOVERNANCE COMMITTEE
OF THE BOARD OF DIRECTORS
The current Compensation and Governance Committee members are
Jerry K. Pearlman (Chairman), James A. Henderson and Donald S.
Perkins. The Compensation and Governance Committee generally has
responsibility for recommending to the Board of Directors
guidelines and standards relating to the determination of
executive and key employee compensation, reviewing the
Companys executive compensation and general corporate
governance policies and reporting to the Board of Directors
regarding the foregoing. The Compensation and Governance
Committee also has responsibility for administering the 2004
Equity Compensation Plan, determining the number of options, if
any, to be granted to the Companys employees and
consultants pursuant to the 2004 Equity Compensation Plan and
reporting to the Board of Directors regarding the foregoing. The
Compensation and Governance Committee held five formal meetings
in 2005.
Base Salaries
In determining the base salaries of the executive officers in
2005, the Compensation and Governance Committee considered the
performance of each executive, the nature of the
executives responsibilities, the salary levels of
executives at comparable high technology companies, including
other publicly-held advanced materials and advanced technologies
companies and the Companys general compensation practices.
Cash Bonuses
Discretionary cash bonuses for executive officers are directly
tied to achievement of specified goals of the Company and are a
function of the criteria which the Compensation and Governance
Committee believes appropriately take into account the specific
areas of responsibility of the particular officer.
Equity Compensation
Periodically, the Compensation and Governance Committee may
grant equity compensation, in the form of stock options,
restricted share rights, and performance share rights, to
executive officers in order to provide a long-term incentive
which is directly tied to the performance of the Companys
stock. These grants provide an incentive to maximize stockholder
value by providing the Companys employees an equity
interest which further aligns their interests with those of the
stockholders. The exercise price of these grants is the fair
market of the underlying Common Stock on the date of grant. In
general, the options vest in equal annual installments over a
three-year period beginning one year after the date of grant, in
certain instances the Board of Directors (or the Compensation
and Governance Committee) can adjust the vesting period for
performance-based options. Restricted share rights typically
cliff vest, all at one time, at a date several years
subsequent to their grant date. Performance restricted share
rights vest upon the achievement of milestones as defined by the
Compensation and Governance Committee. Vesting periods are used
to retain key employees and to emphasize the long-term aspect of
contribution and performance. In making such grants to
executives in 2005, the Compensation and Governance Committee
considered a number of factors, including the performance of
such persons, the Companys performance, achievement of
specific delineated goals, the responsibilities and the relative
position of such persons within the Company, the compensation of
executives in comparable high technology companies and the
number of stock options each such person currently possesses.
Chief Executive Officer Compensation
Joseph Cross has served as the Companys President since
November 1998 and its Chief Executive Officer since December
1998. Under his employment agreement with the Company dated
November 9, 1999,
10
Mr. Cross was paid a base salary of $320,000 in 2005 and
received options to purchase 15,000 shares of common
stock which vest over a three-year period and 2,500 shares
of restricted and performance share rights respectively. The
restricted share rights vest in lump sum or cliff
vest on September 27, 2008, provided that the grantee
has not terminated service prior to the vesting date. The
performance share rights also vest in lump sum or cliff
vest upon achievement of certain performance goals or
milestones on or before January 30, 2009, provided that the
grantee has not terminated service prior to the vesting date. In
determining the level of salary payments and option grants to
Mr. Cross, the Compensation and Governance Committee considered
qualitative factors such as Mr. Crosss strong
leadership role in coordinating the Companys development
of partnering relationships with key customers, the
Companys transition to a producer and supplier of
commercial quantities of nanomaterials, the expansion of the
Companys intellectual property assets, and the development
of new strategic initiatives.
Compliance with Section 162(m)
The Compensation and Governance Committee currently intends for
all compensation paid to the Named Officers to be tax deductible
to the Company pursuant to Section 162(m) of the Internal
Revenue Code of 1986, as amended
(Section 162(m)). Section 162(m) provides
that compensation paid to the Named Officers in excess of
$1,000,000 cannot be deducted by the Company for Federal income
tax purposes unless, in general, (1) such compensation is
performance-based, established by a committee of outside
directors and objective, and (2) the plan or agreement
providing for such performance-based compensation has been
approved in advance by stockholders. The Compensation and
Governance Committee believes that the requirements of
Section 162(m) are uncertain at this time and may
arbitrarily impact the Company. In the future, the Compensation
and Governance Committee may determine to adopt a compensation
program that does not satisfy the conditions of
Section 162(m) if in its judgment, after considering the
additional costs of not satisfying Section 162(m), such
program is appropriate.
|
|
|
Submitted by the Compensation and Governance |
|
Committee of the Board of Directors: |
|
|
Jerry K. Pearlman (Chairman) |
|
James A. Henderson |
|
Donald S. Perkins |
Compensation and Governance Committee Interlocks and Insider
Participation
Pursuant to a consulting agreement effective as of
October 29, 1998, and prior to his appointment as Chairman
of the Board of Directors, Donald S. Perkins, who is Chairman of
the Compensation and Governance Committee, was engaged by the
Company to provide additional services in connection with the
Companys organizational restructuring and refocusing. In
consideration for such services, Mr. Perkins was granted
options to purchase 25,000 shares of Common Stock at
an exercise price of $3.50 per share, of which 20,000
options remain vested but unexercised.
11
REPORT OF THE AUDIT AND FINANCE COMMITTEE
OF THE BOARD OF DIRECTORS
All members of the Audit and Finance Committee are independent,
as that term is defined in the applicable National Association
of Securities Dealers listing standards. Each member of
the Audit and Finance Committee is also financially literate, as
that qualification is interpreted by the Companys Board of
Directors in its business judgment. The Audit and Finance
Committee currently consists of James A. McClung
(Chairman), Jerry K. Pearlman and Donald S. Perkins.
Policies and Mission
The Audit and Finance Committee is responsible for retaining the
Companys independent certified public accountants, engages
in a discussion with the independent accountants regarding the
objectivity and independence of the accountants, reviews the
adequacy of the Audit and Finance Committee Charter, reviews
certain of the Companys Securities and Exchange Commission
filings, reviews significant financial reporting issues with the
Companys chief financial officer, reviews risk management
and internal audit procedures with the Companys chief
financial officer, and engages in any necessary private sessions
with the Companys chief financial officer and independent
accountants.
Audit and Finance Committee Statement
The Audit and Finance Committee has reviewed and discussed the
audited financial statements with Company management; discussed
with the independent auditors the matters required to be
discussed by SAS 61 (Codification of Statements on Auditing
Standards), as modified or supplemented; received a written
disclosure letter from the Companys independent certified
public accountants as required by Independence Standards Board
Standard No. 1 (Independence Standards Board Standard
No. 1, Independence Discussions with Audit Committees), as
modified and supplemented, and has discussed with the
independent certified public accountants the independent
accountants independence; and based on the preceding
review and discussions contained in this paragraph, recommended
to the Board of Directors that the audited financial statements
be included in the Companys Annual Report on
Form 10-K for the
2005 fiscal year for filing with the Securities and Exchange
Commission.
|
|
|
Submitted by the Audit and Finance |
|
Committee of the Board of Directors: |
|
|
James A. McClung (Chairman) |
|
Jerry K. Pearlman |
|
Donald S. Perkins |
12
PERFORMANCE GRAPH
The following graph shows a comparison of cumulative total
returns for the Company, the NASDAQ Market Composite Index and
an index of peer companies selected by the Company during the
period commencing on January 1, 2001 and ending on
December 31, 2005. The comparison assumes $100 was invested
on January 1, 2001 in the Common Stock, the NASDAQ Market
Composite Index and the peer companies selected by the Company
and assumes the reinvestment of all dividends, if any.
COMPARISON OF CUMULATIVE TOTAL RETURNS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Measurement Date |
|
1/1/01 |
|
12/31/01 |
|
12/31/02 |
|
12/31/03 |
|
12/31/04 |
|
12/31/05 |
|
|
|
Nanophase Technologies Corporation |
|
$100.00 |
|
53.55 |
|
25.64 |
|
73.55 |
|
80.64 |
|
51.36 |
|
|
|
Nasdaq |
|
$100.00 |
|
78.95 |
|
54.06 |
|
81.09 |
|
88.06 |
|
89.27 |
|
|
|
Peer Group |
|
$100.00 |
|
99.18 |
|
62.90 |
|
170.85 |
|
179.73 |
|
227.93 |
|
The companies in the peer group, both of which are advanced
materials or advanced technologies companies, are: Landec
Corporation and WSI Industries, Inc. The Company has changed its
peer group by dropping Delta & Pine Land Company. The
Company believes that WSI Industries, Inc. is more compatible
with respect to its business, stage of development and market
capitalization than Delta & Pine Land Company.
The above graph shall not be deemed incorporated by reference by
any general statement incorporating by reference this Proxy
Statement into any filing under the Securities Act or under the
Exchange Act, except to the extent that the Company specifically
incorporates this information by reference, and shall not
otherwise be deemed filed under such Acts.
13
SECURITY OWNERSHIP OF MANAGEMENT AND PRINCIPAL
STOCKHOLDERS
The following table sets forth, as of May 15, 2006 certain
information with respect to the beneficial ownership of the
common stock by (1) each person known by the Company to own
beneficially more than 5% of the outstanding shares of common
stock, (2) each Company director, (3) each of the
Named Officers and (4) all Company executive officers and
directors as a group.
|
|
|
|
|
|
|
|
|
|
|
Number of Shares | |
|
Percent of Shares | |
Name |
|
Beneficially Owned(1) | |
|
Beneficially Owned | |
|
|
| |
|
| |
Bradford T. Whitmore
|
|
|
3,558,007 |
(2) |
|
|
19.76 |
% |
Spurgeon Corporation
|
|
|
3,285,195 |
(3) |
|
|
18.25 |
% |
Grace Brothers, Ltd.
|
|
|
2,985,195 |
(4) |
|
|
16.58 |
% |
Grace Investments, Ltd.
|
|
|
300,000 |
(5) |
|
|
1.67 |
% |
Altana Chemie, AG
|
|
|
1,256,281 |
(6) |
|
|
6.98 |
% |
Joseph E. Cross
|
|
|
466,500 |
(7) |
|
|
2.53 |
% |
James A. Henderson
|
|
|
22,410 |
(8) |
|
|
* |
|
Richard W. Siegel, Ph.D.
|
|
|
275,132 |
(9) |
|
|
1.52 |
% |
James McClung
|
|
|
41,771 |
(10) |
|
|
* |
|
Jerry Pearlman
|
|
|
39,948 |
(11) |
|
|
* |
|
Donald S. Perkins
|
|
|
78,812 |
(12) |
|
|
* |
|
R. Janet Whitmore
|
|
|
162,557 |
(13) |
|
|
* |
|
Daniel S. Bilicki
|
|
|
182,100 |
(14) |
|
|
1.00 |
% |
Jess Jankowski
|
|
|
110,922 |
(15) |
|
|
* |
|
Richard W. Brotzman, Ph.D.
|
|
|
186,347 |
(16) |
|
|
1.02 |
% |
Robert Haines
|
|
|
106,667 |
(17) |
|
|
* |
|
All executive officers and directors as a group (11 persons)
|
|
|
1,673,166 |
(18) |
|
|
8.73 |
% |
Unless otherwise indicated below, the persons address is the
same as the address for the Company.
|
|
|
|
* |
Denotes beneficial ownership of less than one percent. |
|
|
|
|
(1) |
Beneficial ownership is determined in accordance with the rules
of the Securities and Exchange Commission (the
Commission). Unless otherwise indicated below, the
persons in the above table have sole voting and investment power
with respect to all shares of common stock shown as beneficially
owned by them. |
|
|
(2) |
Includes 2,985,195 shares of common stock held by Grace
Brothers, Ltd., 300,000 shares of common stock held by
Grace Investments, Ltd. and 272,812 shares held by Bradford
T. Whitmore. Mr. Whitmore is a general partner of Grace
Brothers, Ltd. and is the sole owner of an entity which is a
general partner of Grace Investments, Ltd. In such capacities,
Mr. Whitmore shares voting and investment power with
respect to the shares of common stock held by the Grace
entities. This information is based on information reported on
Schedule 13D/ A filed on September 3, 2004 with the
Commission by Mr. Whitmore. The address of the stockholder
is 1560 Sherman Avenue, Suite 900, Evanston, Illinois 60201. |
|
|
(3) |
Includes 2,985,195 shares of common stock held by Grace
Brothers, Ltd. and 300,000 shares of common stock held by
Grace Investments, Ltd. Spurgeon Corporation is a general
partner of both Grace entities and shares voting and investment
power with respect to the shares of common stock held by such
Grace entities. This information is based on information
reported on Schedule 13D/ A filed on September 3, 2004
with the Commission by Spurgeon Corporation. The address of the
stockholder is 1560 Sherman Avenue, Suite 900, Evanston,
Illinois 60201. |
|
|
(4) |
This information is based on information reported on
Schedule 13D/ A filed on September 3, 2004 with the
Commission by Spurgeon Corporation and Bradford T. Whitmore. The
address of the stockholder is 1560 Sherman Avenue,
Suite 900, Evanston, Illinois 60201. |
14
|
|
|
|
(5) |
This information is based on information reported on
Schedule 13D/ A filed on September 3, 2004 with the
Commission by Spurgeon Corporation and Bradford T. Whitmore. The
address of the stockholder is 1560 Sherman Avenue,
Suite 900, Evanston, Illinois 60201. |
|
|
(6) |
Consist of unregistered common stock, and therefore not freely
saleable, until registered for resale or otherwise saleable
pursuant to Rule 144. |
|
|
(7) |
Includes 460,000 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
|
(8) |
Includes 14,000 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
|
(9) |
Includes 42,760 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
|
(10) |
Includes 18,000 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(11) |
Includes 18,000 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(12) |
Includes 36,668 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(13) |
Includes 6,666 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(14) |
Includes 174,100 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(15) |
Includes 106,622 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(16) |
Consists of 183,347 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(17) |
Consists of 103,667 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
|
(18) |
Includes 1,673,166 shares of common stock issuable upon
exercise of options exercisable currently or within 60 days
of May 15, 2006. |
Equity Compensation Plan Information
The following table gives information about our common stock
that may be issued upon the exercise of options, warrants, and
rights under all of our existing compensation plans as of
December 31, 2005, including the 1992 Amended and Restated
Stock Option Plan and the 2001 and 2004 Equity Compensation Plan
and the 2005 Non-Employee Director Restricted Stock Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) Number of Securities | |
|
|
|
|
(a) Number of | |
|
|
|
Remaining Available for | |
|
(d) Total of | |
|
|
Securities to be Issued | |
|
(b) Weighted Average | |
|
Future Issuance Under | |
|
Securities | |
|
|
Upon Exercise of | |
|
Exercise Price of | |
|
Equity Compensation Plans | |
|
Reflected in | |
|
|
Outstanding Options, | |
|
Outstanding Options, | |
|
(Excluding Securities | |
|
Columns | |
Plan Category |
|
Warrants and Rights | |
|
Warrants, and Rights | |
|
Reflected in Column (a)) | |
|
(a) and (c) | |
|
|
| |
|
| |
|
| |
|
| |
Plans Approved by Shareholders
|
|
|
1,740,347 |
(1) |
|
$ |
5.92 |
|
|
|
709,501 |
(2) |
|
|
2,449,848 |
|
Plans Not Approved by Shareholders
|
|
|
None |
|
|
$ |
|
|
|
|
None |
|
|
|
|
|
|
|
(1) |
Consists of the 1992 Amended and Restated Stock Option Plan, the
2001 and 2004 Equity Compensation Plan, and shares of authorized
but unissued Preferred Stock |
|
(2) |
Consists of shares available for future issuance under the 2004
Equity Compensation Plan and the 2005 Non-Employee Director
Restricted Stock Plan. |
15
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
In addition to items listed elsewhere in this Proxy Statement,
on September 5, 2003, in anticipation of the
September 8, 2003 private placement to Grace Brothers Ltd.,
the Company amended its existing Stockholder Rights Agreement to
revise the beneficial ownership threshold at which a person or
group of persons becomes an acquiring person and
triggers certain provisions under the Stockholder Rights
Agreement. As revised, a person or group would become an
acquiring person if that person or group becomes the
beneficial owner of 35% or more of the outstanding shares of the
Companys stock. Prior to such amendment, the beneficial
ownership threshold was 25%. On September 8, 2003, the
Company issued 453,001 shares of its common stock to Grace
Brothers Ltd. at a purchase price of $4.415 per share
together with a warrant to purchase a like number of shares of
common stock during the next twelve months also at a price of
$4.415 per share. The share price for the common stock was
determined based on the fifteen-day market closing average for
the Companys stock ending September 5, 2003. On
September 2, 2004 the warrants were exercised to acquire
453,001 newly issued shares of common stock. Grace Brothers,
Ltd. beneficially owns approximately 19.9% of the Companys
outstanding common stock. Ms. R. Janet Whitmore is a sister
of Bradford Whitmore who serves as the general partner of Grace
Brothers, Ltd.
On March 23, 2004, the Company entered into a joint
development agreement with Altana Chemie, AG
(Altana) in order to explore new product
applications in fields that are mutually beneficial to both
companies. Pursuant to the agreement, the Company and Altana
have granted each other, subject to limited exceptions,
exclusive rights for the development and purchase of
nanomaterials for use in paints, coatings, inks, polymers and
plastics, varnishes, and similar applications. In connection
with this agreement the Company sold, in a private placement to
Altana, 1,256,281 shares of common stock at $7.96 per
share and received gross proceeds of $10 million. Altana
beneficially owns approximately 7% of the Companys
outstanding common stock.
On October 27, 2005, the Company received a fully-signed
Promissory Note executed by BYK-Chemie USA (BYK), a
customer of the Company, in favor of the Company in an original
principal amount of $1,597,420. The proceeds of the Promissory
Note are to be used to buy, install and commission certain
equipment which is then to be used for fulfillment of orders by
BYK and other uses. The outstanding principal balance of the
Promissory Note is payable in three equal installments on
January 30, 2009, April 30, 2009 and December 31,
2009. Interest accrues and is payable on a quarterly basis one
year after the equipment referenced above is installed at the
rate of 100 basis points over the average daily London
Inter-Bank Offered Rate for the preceding quarter.
PROPOSAL 2
AMENDMENT TO CERTIFICATE OF INCORPORATION
TO INCREASE AUTHORIZED SHARES OF COMMON STOCK
The Board of Directors has approved and recommends that the
shareholders adopt an amendment to the Companys
Certificate of Incorporation to increase the total authorized
shares of common stock of the Company from 25,000,000 to
30,000,000. The Company is currently authorized to issue
24,088 shares of preferred stock and the proposed amendment
will not affect this authorization. The form of the proposed
amendment is included as Exhibit A of this Proxy
Statement.
If the amendment is adopted, it will become effective upon the
filing of a Certificate of Amendment to the Certificate of
Incorporation with the Secretary of State of the State of
Delaware.
Purpose of the Proposed Amendment Presently,
the Board of Directors has no immediate or specific plans to
issue the additional authorized shares of common stock. The
Board desires, instead, to have the shares available to provide
the Company with flexibility in responding to potential business
opportunities in the future. The additional shares may be used
for various purposes at the direction of the Board of Directors,
when such issuance is deemed to be in the best interests of the
Company. These purposes may include: establishing strategic
relationships with other companies, expanding business or
product lines through the acquisition of other businesses or
products, and other corporate purposes.
16
The additional shares of common stock to be authorized by
adoption of the amendment would have rights identical to the
currently outstanding shares of common stock. Adoption of the
proposed amendment and issuance of the common stock would not
directly affect the rights of the holders of currently
outstanding common stock, but effects incidental to the increase
are possible. The issuance may decrease the proportionate
holdings of existing stockholders and could have the effect of
diluting voting power per share.
Required Vote To be approved, Proposal 2
must receive For votes from a majority of the shares
outstanding on the record date. As a result, abstentions and
broker non-votes will have the same effect as a vote
Against such proposal.
PROPOSAL 3
AMENDMENT TO THE 2004
EQUITY COMPENSATION PLAN
The Compensation and Governance Committee has approved and
recommends that the shareholders adopt an amendment to the
Companys 2004 Equity Compensation Plan (the
Plan). The proposed amendment to the Plan would
(a) increase the number of shares available for grants
under the Plan to 1,200,000, (b) increase the yearly cap on
grants available under the Plan from 200,000 to
300,000 shares (subject to existing exceptions contained in
the Plan), and (c) decrease the cap on grants to any
individual in any year from 15% of any class to 10% of any
class. The amendment would not change any other aspects of the
Plan.
To effect the amendment to the Plan, the first clause of the
second sentence of Section 1.3(a)(i) would be amended to
read as follows: Subject to adjustments provided in
Section 1.3(b) below, the aggregate number of Shares
available for Grants under the Plan shall be
1,200,000 Shares. Section 1.3(a)(ii)(A) of the
Plan will also be amended to read: Subject to adjustments
as provided in Section 1.3(b) below, the maximum aggregate
number of Shares that shall be subject to Grants made under this
Plan during any calendar year shall be 300,000. Finally,
the first sentence of Section 1.3(a)(ii)(B) of the Plan
would be amended to read: No Grantee shall receive more
than ten (10) percent of the aggregate number of any class
of Grants made during any calendar year.
Purpose of the Amendment The Companys
Board believes that the proposed amendment will strengthen the
Companys continued capacity to attract and retain the
services of key employees who will contribute to the
Companys long-term growth and financial success. The Board
recognizes that there is significant competition among
high-technology businesses for talented employees and that these
employees play an important role in maintaining the
Companys technology leadership position in nanomaterials
and advanced nanoengineered products. The Board believes that
the equity compensation available under the Plan, and the
enhanced flexibility provided by the amendment, is vital to our
ability to secure and build the Companys talented human
resources and thereby remain competitive and a technology leader
in our industry.
Vote Required The NASD Marketplace Rules
require shareholder approval when an equity compensation plan is
materially amended. As a Result, Proposal 3 must receive
For votes from a majority of the shares represented
in person or by proxy to become effective. If you abstain from
voting, it will have the same effect as an Against
vote. Broker non-votes will not be considered present and
entitled to vote, and will not have any effect for purposes of
determining whether Proposal 3 has been approved.
MISCELLANEOUS AND OTHER MATTERS
Solicitation The cost of this proxy
solicitation will be borne by the Company. The Company may
request banks, brokers, fiduciaries, custodians, nominees and
certain other record holders to send proxies, proxy statements
and other materials to their principals at the Companys
expense. Such banks, brokers, fiduciaries, custodians, nominees
and other record holders will be reimbursed by the Company for
their reasonable
out-of-pocket expenses
of solicitation. The Company does not anticipate that costs and
expenses
17
incurred in connection with this proxy solicitation will exceed
an amount normally expended for a proxy solicitation for an
election of directors in the absence of a contest.
Proposals of Stockholders Proposals of
stockholders (1) intended to be considered at the
Companys 2007 Annual Meeting of Stockholders (the
2007 Annual Meeting) and (2) to be considered
for inclusion in the Companys proxy statement and proxy
for the 2006 Annual Meeting, must be received by the Secretary
of the Company on or before January 3, 2007. If a
stockholder submits a proposal to be considered at the 2007
Annual Meeting other than in accordance with
Rule 14a-8 under
the Securities Exchange Act of 1934, as amended, and does not
provide notice of such proposal to the Company by
March 19, 2007, the holders of any proxy solicited by
the Companys Board of Directors for use at such meeting
will have discretionary authority to vote with respect to any
proposal as to which timely notice is not given.
Independent Certified Public Accountants The
Board of Directors, upon the recommendation of the Audit and
Finance Committee, has appointed McGladrey and Pullen, LLP,
independent certified public accountants, as auditors of the
Companys financial statements for the year ended
December 31, 2006. McGladrey and Pullen, LLP has been
engaged as auditors for the Company beginning in November 2001.
The following fees were incurred by Nanophase Technologies
Corporation for the services of McGladrey & Pullen, LLP
in relation to the 2005 fiscal year.
Audit Fees. The aggregate amount billed by our principal
accountant, McGladrey & Pullen, LLP, for audit services
performed during the fiscal years ended December 31, 2005
and 2004 was $238,000 and $339,140, respectively. Audit services
include the auditing of financial statements, quarterly reviews,
statutory audits and the preparation of consents and review of
registration statements.
Audit Related Fees. McGladrey & Pullen, LLP did
not perform audit related services during the fiscal years ended
December 31, 2005 and 2004. Audit related services would
include employee benefit plan audits, due diligence assistance,
internal control review assistance and audit or attestation
services not required by statute or regulation.
Tax Fees. Total fees billed by RSM McGladrey, Inc. (an
affiliate of McGladrey & Pullen, LLP) for tax related
services for the fiscal years ended December 31, 2005 and
2004 were $7,575 and $6,500, respectively. These services
include tax related research and general tax services in
connection with transactions and legislation.
All Other Fees. Other than those fees described above,
there were no other fees billed for services performed by
McGladrey & Pullen, LLP during the fiscal years ended
December 31, 2005 and 2004.
All of the fees described above were approved by
Nanophases Audit and Finance Committee.
Audit and Finance Committee Pre-Approval Policies and
Procedures. Nanophases Audit and Finance Committee
pre-approves the audit and non-audit services performed by
McGladrey & Pullen, LLP, our principal accountants, and
RSM McGladrey, Inc. (an affiliate of McGladrey &
Pullen, LLP) in order to assure that the provision of such
services does not impair McGladrey & Pullen, LLPs
independence. Unless a type of service to be provided by
McGladrey & Pullen, LLP and RSM McGladrey, Inc. (an
affiliate of McGladrey & Pullen, LLP) has received
general pre-approval, it will require specific pre-approval by
the Audit and Finance Committee. In addition, any proposed
services exceeding pre-approval cost levels will require
specific pre-approval by the Audit and Finance Committee. The
term of any pre-approval is 12 months from the date of
pre-approval, unless the Audit and Finance Committee
specifically provides for a different period. The Audit and
Finance Committee will periodically revise the list of
pre-approved services, based on subsequent determinations, and
has delegated pre-approval authority to the Chairman and Vice
Chairman of the Audit and Finance Committee. In the event the
Chairman or Vice Chairman exercises such delegated authority,
they shall report such pre-approval decisions to the Audit and
Finance Committee at its next scheduled meeting. The Audit and
Finance Committee does not delegate its responsibilities to
pre-approve services performed by the independent auditor to
management.
18
Other Business The Board of Directors is not
aware of any other matters to be presented at the Annual Meeting
other than those mentioned in this Proxy Statement and the
Companys Notice of Annual Meeting of Stockholders enclosed
herewith. If any other matters are properly brought before the
Annual Meeting, however, it is intended that the persons named
in the proxies will vote such proxies as the Board of Directors
directs.
Section 16(a) Beneficial Ownership Reporting
Compliance Section 16 of the Securities
Exchange Act of 1934, as amended (the Exchange Act),
requires the Companys officers (as defined under
Section 16), directors and persons who beneficially own
greater than 10% of a registered class of the Companys
equity securities to file reports of ownership and changes in
ownership with the Securities and Exchange Commission. Based
solely on a review of the forms it has received and on written
representations from certain reporting persons that no such
forms were required for them, the Company believes that during
2005 all Section 16 filing requirements applicable to its
officers, directors and 10% beneficial owners were complied with
by such persons.
Additional Information The Company will
furnish without charge a copy of its Annual Report on
Form 10-K for its
year ended December 31, 2005, as filed with the Commission,
upon the written request of any person who is a stockholder as
of the Record Date, and will provide copies of the exhibits to
such Form 10-K
upon payment of a reasonable fee which shall not exceed the
Companys reasonable expenses in connection therewith.
Requests for such materials should be directed to Nanophase
Technologies Corporation, 1319 Marquette Drive, Romeoville,
Illinois 60446, Attention: Nancy Baldwin, Manager of Investor
Relations.
|
|
|
By order of the Board of Directors |
|
|
|
|
|
|
Jess Jankowski |
|
Secretary |
Romeoville, Illinois
June 23, 2006
ALL STOCKHOLDERS ARE REQUESTED TO COMPLETE,
DATE, SIGN AND RETURN THE ENCLOSED PROXY PROMPTLY.
19
EXHIBIT A
FIRST AMENDMENT
TO
THE CERTIFICATE OF INCORPORATION
OF
NANOPHASE TECHNOLOGIES CORPORATION
Pursuant to the Certificate of Incorporation of Nanophase
Technologies Corporation and Delaware General Corporation Law,
the undersigned corporation hereby adopts the following
Amendment to its Certificate of Incorporation:
FIRST: The name of the Corporation is Nanophase
Technologies Corporation
SECOND: Article IV, Section A of the
Certificate of Incorporation of the Corporation is hereby
amended as follows:
ARTICLE IV
A. The Corporation shall have authority to issue the
following classes of stock in the number of shares and at the
par value as indicated opposite the name of the class:
|
|
|
|
|
|
|
|
|
|
|
Number of Shares | |
|
Par Value | |
Class |
|
Authorized | |
|
per Share | |
|
|
| |
|
| |
Common Stock
(the Common Stock)
|
|
|
30,000,000 |
|
|
$ |
.01 |
|
Preferred Stock
(the Preferred Stock)
|
|
|
24,088 |
|
|
$ |
.01 |
|
The designations and the powers, preferences and relative
participating, option or other rights of the Common and
Preferred stockholders, and the qualifications, limitations or
restrictions thereof remain unchanged.
THIRD: Pursuant to Section 242 of the Delaware
General Corporation Law, a majority of the outstanding stock
entitled to vote thereon and a majority of the outstanding stock
of each class entitled to vote thereon as a class has duly
approved, the amendment to the Certificate of Incorporation of
the Corporation, as amended, set forth in this Certificate of
Amendment.
FOURTH: That said amendment was duly adopted, in
accordance with the provisions of Section 242 of the
General Corporation law of the State of Delaware.
FIFTH: This amendment shall be effective on the date this
Certificate of Amendment is filed and accepted by the Secretary
of State of the State of Delaware.
IN WITNESS WHEREOF, the undersigned, being the Chief Executive
Officer of the Corporation, for purposes of amending its
Certificate of Incorporation pursuant to the General Corporation
Law of the State of Delaware, acknowledges that it is his act
and deed and that the facts stated herein are true, and has
signed this instrument
this day
of ,
2006.
|
|
|
Nanophase Technologies Corporation |
|
|
|
|
|
|
Joseph E. Cross, |
|
|
Chief Executive Officer |
NANOPHASE TECHNOLOGIES CORPORATION
NANOPHASE TECHNOLOGIES CORPORATION
1319 MARQUETTE DRIVE
ROMEOVILLE, ILLINOIS 60446
PROXY FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JULY 24, 2006
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned stockholder(s) hereby appoints Joseph E. Cross and Jess Jankowski and each of them,
with full power of substitution, as attorneys and proxies for, and in the name and place of, the
undersigned, and hereby authorizes each of them to represent and to vote all of the shares which
the undersigned is entitled to vote at the Annual Meeting of Stockholders of Nanophase Technologies
Corporation to be held at Nanophase Technologies Corporation, 1319 Marquette Drive, Romeoville,
Illinois, 60446, on Monday, July 24, 2006 at 9:30 a.m., local time, and at any adjournments
thereof, upon the matters as set forth in the Notice of Annual Meeting of Stockholders and Proxy
Statement, receipt of which is hereby acknowledged.
THIS PROXY, WHEN PROPERLY EXECUTED AND RETURNED IN A TIMELY MANNER, WILL BE VOTED AT THE ANNUAL
MEETING AND AT ANY ADJOURNMENTS THEREOF IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED
STOCKHOLDER(S). IF NO CONTRARY INDICATION IS MADE, THE PROXY WILL BE VOTED FOR NOMINEES LISTED IN
PROPOSAL 1, FOR PROPOSALS 2 AND 3 AND IN ACCORDANCE WITH THE JUDGMENT OF THE PERSONS NAMED AS
PROXIES HEREIN ON ANY OTHER MATTERS THAT MAY PROPERLY COME BEFORE THE ANNUAL MEETING.
PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED ENVELOPE.
(continued, and to be signed and dated, on reverse side)
á FOLD AND DETACH HERE á
NANOPHASE TECHNOLOGIES CORPORATION
|
|
|
|
|
|
|
|
PLEASE MARK VOTE IN OVAL IN THE FOLLOWING MANNER USING DARK INK ONLY.
|
|
|
þ |
|
|
|
|
|
|
|
|
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE FOR NOMINEES LISTED IN PROPOSAL 1 AND
FOR PROPOSALS 2 AND 3 .
1. |
|
ELECTION OF CLASS III DIRECTORS. |
|
|
|
For nominees listed below
|
|
o |
|
|
|
Withhold authority to vote
|
|
o |
|
|
|
(except as marked to the contrary below)
|
|
o |
|
|
|
for nominees listed below
|
|
o |
(INSTRUCTION: TO WITHHOLD AUTHORITY TO VOTE FOR THE INDIVIDUAL
NOMINEES, STRIKE A LINE THROUGH THE NOMINEES NAME BELOW)
Jerry K. Pearlman
Donald S. Perkins
2. |
|
PROPOSAL TO AMEND THE COMPANYS CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF
AUTHORIZED SHARES TO 30,000,000 |
FOR o
AGAINST o
ABSTAIN o
3. |
|
PROPOSAL TO AMEND THE COMPANYS 2004 EQUITY COMPENSATION PLAN |
FOR o
AGAINST o
ABSTAIN o
4. |
|
EACH OF THE PERSONS NAMED AS PROXIES HEREIN ARE AUTHORIZED, IN SUCH PERSONS DISCRETION, TO
VOTE UPON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE ANNUAL MEETING, OR ANY
ADJOURNMENTS THEREOF. |
Date: _______________________, 2006
Signature (if held jointly)
Please date this Proxy and sign it exactly as your name(s) appears hereon.
When shares are held by joint tenants, both should sign. When signing as an attorney, executor,
administrator, trustee, guardian or other fiduciary, please indicate your capacity. If you sign
for a corporation, please print full corporate name and indicate capacity of duly authorized
officer executing on behalf of the corporation.
If you sign for a partnership, please print full partnership name and indicate capacity of duly
authorized person executing on behalf of the partnership.
PLEASE VOTE, SIGN EXACTLY AS NAME APPEARS ABOVE, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE
ENCLOSED ENVELOPE.
á FOLD AND DETACH HERE á